Aquestive Therapeutics, Inc.
AQST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001398733
In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Aquestive Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 98 | 2 | 117 | +21 |
| Shares | 42.5M | 5.46M | 46.8M | +9.68M (+26.1%) |
| Value | $110.7M | $14.2M | $232.4M | +$136.0M (+141.0%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (38)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (17)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Jump Financial, LLC | 130,920 | $340.4K |
| Sanctuary Advisors, LLC | 63,270 | $257.5K |
| CI Private Wealth, LLC | 95,813 | $249.1K |
| Marshall Wace, LLP | 77,016 | $200.2K |
| Alpine Global Management, LLC | 72,177 | $187.7K |
| Connor, Clark & Lunn Investment Management Ltd. | 47,817 | $124.3K |
| PBMares Wealth Management LLC | 28,407 | $73.9K |
| Walleye Capital LLC | 26,892 | $69.9K |
| Two Sigma Advisers, LP | 24,200 | $62.9K |
| Marathon Trading Investment Management LLC | 18,225 | $47.4K |
| Dynamic Technology Lab Private Ltd | 15,870 | $41.0K |
| Vontobel Holding Ltd. | 14,000 | $36.4K |
| State of Wyoming | 13,176 | $34.3K |
| Man Group plc | 12,653 | $32.9K |
| LPL Financial LLC | 10,113 | $26.3K |
| Dixon Mitchell Investment Counsel Inc. | 4,000 | $10.4K |
| HighMark Wealth Management LLC | 50 | $130 |
Not filed for Q3 2024 yet (2)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 5,454,743 | $14.2M |
| ICA Group Wealth Management, LLC | 2,590 | $6.73K |